Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Vericel (VCEL) Stock Forecast & Price Target

$44.91
-0.16 (-0.36%)
(As of 01:00 PM ET)

Vericel - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$48.17
7.25% Upside
High Forecast$55.00
Average Forecast$48.17
Low Forecast$39.00
TypeCurrent Forecast
7/4/23 to 7/3/24
1 Month Ago
6/4/23 to 6/3/24
3 Months Ago
4/5/23 to 4/4/24
1 Year Ago
7/4/22 to 7/4/23
Consensus Rating
Buy
Buy
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$48.17$46.80$46.40$37.25
Forecasted Upside7.25% Upside19.93% Upside20.70% Upside25.87% Upside

VCEL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VCEL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Vericel Stock vs. The Competition

TypeVericelMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.71
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside6.87% Upside1,116.81% Upside12.05% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/20/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Jennings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$55.00+26.82%
5/9/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$53.00 ➝ $55.00+13.22%
3/26/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$54.00+12.64%
10/16/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kratky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
10/16/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$42.00+28.01%
9/21/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$44.00+29.83%
AI depends on this... Your retirement could too! (Ad)

Imagine owning a piece of the backbone powering the AI revolution. Wall Street says it's extremely undervalued - a downright steal compared to peers. We call it the "Last Retirement Stock You'll Ever Need."

Get all the urgent details here >>>
8/8/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$39.00+22.26%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:38 PM ET.

VCEL Forecast - Frequently Asked Questions

What is Vericel's stock forecast and purchase recommendation?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Vericel is $48.17, with a high forecast of $55.00 and a low forecast of $39.00. The consensus rating for Vericel stock is Buy based on the current 7 buy ratings for VCEL. Learn more on VCEL's analyst rating history.

Do Wall Street analysts like Vericel more than its competitors?

Analysts like Vericel more than other "medical" companies. The consensus rating for Vericel is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how VCEL compares to other companies.

Does Vericel's stock price have much upside?

According to analysts, Vericel's stock has a predicted upside of 21.18% based on their 12-month stock forecasts.

What analysts cover Vericel?

Vericel has been rated by research analysts at HC Wainwright, and TD Cowen in the past 90 days.


This page (NASDAQ:VCEL) was last updated on 7/3/2024 by MarketBeat.com Staff

From Our Partners